Incidence and outcome of lupus nephritis in French Polynesia
- PMID: 28933339
- DOI: 10.5414/CN109194
Incidence and outcome of lupus nephritis in French Polynesia
Abstract
Objective: Outcomes of systemic lupus erythematosus (SLE) and lupus nephritis (LN) are highly heterogeneous among some populations because of interactions between genetic, epigenetic, environmental, and socioeconomic factors. A better characterization of social and ethnic disparities in mixed populations may thus help to develop individualized treatment regimens.
Materials and methods: Retrospective observational study including all patients with LN diagnosed between January 1993 and January 2014 in the only Nephrology Department of French Polynesia.
Results: The annual incidence of SLE and LN in French Polynesia was 3.6 and 0.96 per 100,000, respectively. Among the 45 patients with biopsy-proven LN (pediatric onset, 26.7%), LN occurred during the first SLE flare-up in 68.8%. At presentation, median eGFR was 72 mL/min/1.73m2 (31 - 105), 32 patients had class-III/IV active glomerulonephritis (GN), and 10 had pure or mixed class-V GN. During the follow-up, 5 patients died (11.1%) and 2 reached end-stage renal disease (4.4%). Cumulative incidences of complete and partial renal responses were 31.1% and 40% at 12 months. Complete renal response (CR)<bold> </bold>was only predicted by renal presentation (lack of leukocyturia, low proteinuria). Among the 36 patients with renal response, 18 relapsed. Maintenance treatment (mycophenolate mofetil) and place of residence (Windward Islands as compared to remote islands) were the only factors that protected from relapse.
Conclusion: Renal presentation was the main predictive factor for a renal response whereas geographical residence and maintenance-treatment regimen were predictive of LN relapses in patients from French Polynesia, an area characterized by a specific genetic background and including several isolated islands that have limited access to healthcare. .
Similar articles
-
Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.Lupus. 2016 Apr;25(5):547-57. doi: 10.1177/0961203315619031. Epub 2015 Dec 3. Lupus. 2016. PMID: 26637291
-
Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experience.Lupus. 2022 Apr;31(5):588-595. doi: 10.1177/09612033221088437. Epub 2022 Mar 22. Lupus. 2022. PMID: 35316102
-
Incidence and disease severity of anti-neutrophil cytoplasmic antibody-associated nephritis are higher than in lupus nephritis in Sweden.Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i23-30. doi: 10.1093/ndt/gfu396. Epub 2014 Dec 23. Nephrol Dial Transplant. 2015. PMID: 25540097
-
Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression.Lupus. 2020 Aug;29(9):1011-1020. doi: 10.1177/0961203320932219. Epub 2020 Jun 22. Lupus. 2020. PMID: 32571142 Free PMC article. Review.
-
Update on Lupus Nephritis: Core Curriculum 2020.Am J Kidney Dis. 2020 Aug;76(2):265-281. doi: 10.1053/j.ajkd.2019.10.017. Epub 2020 Mar 24. Am J Kidney Dis. 2020. PMID: 32220510 Review.
Cited by
-
Peripheral CD4 +CD8 + double positive T cells: A potential marker to evaluate renal impairment susceptibility during systemic lupus erythematosus.J Biomed Res. 2022 Sep 28;37(1):59-68. doi: 10.7555/JBR.36.20220094. Online ahead of print. J Biomed Res. 2022. PMID: 36625011 Free PMC article.
-
Epidemiology of End-Stage Kidney Disease in French Polynesia: A Plea for Standardized Diagnosis Workflow in Young Adults of First Nations People.Kidney Int Rep. 2024 Feb 4;9(4):1111-1114. doi: 10.1016/j.ekir.2024.01.056. eCollection 2024 Apr. Kidney Int Rep. 2024. PMID: 38765559 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous